Resminostat Hydrochloride

盐酸瑞米诺司他

Report date: 2024/04/26 17:58:26
NME

Base Information

Drug NameResminostat Hydrochloride
Drug Alias NameresminostatResminostat-4-SCKinselbyYHI-1001BYK-408740 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsColorectal NeoplasmsCarcinoma, HepatocellularSezary Syndrome +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumPoland +[16] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNycomed
China Registration ClassN/A

Develop Information

Active Companies4sc Ag
Inactive CompaniesYakult Honsha Co Ltd
Active IndicationsSezary SyndromeMycosis FungoidesLymphoma, T-Cell, Cutaneous
Inactive IndicationsColorectal NeoplasmsCarcinoma, HepatocellularHodgkin Disease

Other Information

ATC CodeN/A
Related LinksWikipedia